Development of surface conjugated block co polymeric micelles as targeted therapeutics: characterization and in-vitro cell viability
暂无分享,去创建一个
[1] Susheel Kumar,et al. Exploring the Surfactant structure efficacy in controlling growth and stability of HgS Nanoparticles in aqueous medium , 2022, Chemical Physics Impact.
[2] R. Verma,et al. Label free serum albumin nanoparticles for bioimaging and Trojan horse like drug delivery , 2021, Journal of Science: Advanced Materials and Devices.
[3] W. Grimm. Stability Testing: Photostability Testing of New Drug Substances and Products , 2021, Handbook of Pharmaceutical Manufacturing Formulations, Second Edition.
[4] Wentao Liu,et al. Amphiphilic poly(caprolactone-b-N-hydroxyethyl acrylamide) micelles for controlled drug delivery , 2020, RSC advances.
[5] B. Sipos,et al. Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration , 2020, Pharmaceutics.
[6] Yuyuan Tian,et al. Total Iron Measurement in Human Serum With a Novel Smartphone-Based Assay , 2020, IEEE Journal of Translational Engineering in Health and Medicine.
[7] T. Etrych,et al. Micelle-Forming Block Copolymers Tailored for Inhibition of P-gp-Mediated Multidrug Resistance: Structure to Activity Relationship , 2019, Pharmaceutics.
[8] N. Hioka,et al. "Biotin-targeted mixed liposomes: A smart strategy for selective release of a photosensitizer agent in cancer cells". , 2019, Materials science & engineering. C, Materials for biological applications.
[9] J. Kleijn,et al. Bovine beta-casein micelles as delivery systems for hydrophobic flavonoids , 2019, Food Hydrocolloids.
[10] A. Dharamsi,et al. Application of Failure Mode Effect Analysis in Wurster-Based Pelletization Technology: a Technical Note , 2019, AAPS PharmSciTech.
[11] M. Hazekawa,et al. Evaluation of IC50 levels immediately after treatment with anticancer reagents using a real-time cell monitoring device. , 2019, Experimental and therapeutic medicine.
[12] Sharvil Patil,et al. Harmine-loaded galactosylated pluronic F68-gelucire 44/14 mixed micelles for liver targeting , 2019, Drug development and industrial pharmacy.
[13] Yuejun Kang,et al. Reduction-active polymeric prodrug micelles based on α-cyclodextrin polyrotaxanes for triggered drug release and enhanced cancer therapy. , 2018, Carbohydrate polymers.
[14] Kazunori Kataoka,et al. Block Copolymer Micelles in Nanomedicine Applications. , 2018, Chemical reviews.
[15] B. Chudzik-Rząd,et al. Mixed micelles as drug delivery nanocarriers , 2018 .
[16] E. Essa,et al. Fast disintegrating tablets of amiodarone for intra-oral administration - , 2017 .
[17] K. Somasundaram,et al. Biotin Decorated Gold Nanoparticles for Targeted Delivery of a Smart-Linked Anticancer Active Copper Complex: In Vitro and In Vivo Studies. , 2016, Bioconjugate chemistry.
[18] G. Lin,et al. Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy. , 2016, International journal of pharmaceutics.
[19] M. Amini,et al. Nimodipine-Loaded Pluronic® Block Copolymer Micelles: Preparation, Characterization, In-vitro and In-vivo Studies , 2016, Iranian journal of pharmaceutical research : IJPR.
[20] F. Ungaro,et al. Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells. , 2016, International journal of pharmaceutics.
[21] Brian Kelley,et al. Integration of QbD risk assessment tools and overall risk management. , 2016, Biologicals : journal of the International Association of Biological Standardization.
[22] Xuesi Chen,et al. PCL–F68–PCL/PLGA–PEG–PLGA mixed micelles mediated delivery of mitoxantrone for reversing multidrug resistant in breast cancer , 2016 .
[23] A. Hezma,et al. Spectroscopic studies and thermal properties of PCL/PMMA biopolymer blend , 2016 .
[24] O. Farokhzad,et al. Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. , 2016, Chemical reviews.
[25] J. Cortes,et al. Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial. , 2015, JAMA oncology.
[26] Naveen Chella,et al. Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs – a case study with valsartan , 2015, Drug development and industrial pharmacy.
[27] Yan Zhang,et al. Synthesis of functionalized Pluronic-b-poly(ε-caprolactone) and the comparative study of their pendant groups on the cellular internalization behavior , 2015, Journal of Materials Science: Materials in Medicine.
[28] E. Ramos-Moore,et al. Effects of pluronic F68 micellization on the viability of neuronal cells in culture , 2013 .
[29] A. Divsalar,et al. Development and application of an HPLC method for erlotinib protein binding studies. , 2013, Advanced pharmaceutical bulletin.
[30] T. Ren,et al. Pluronic F127 nanomicelles engineered with nuclear localized functionality for targeted drug delivery. , 2013, Materials science & engineering. C, Materials for biological applications.
[31] C. Sharma,et al. In vitro cytotoxicity and cellular uptake of curcumin-loaded Pluronic/Polycaprolactone micelles in colorectal adenocarcinoma cells , 2013, Journal of biomaterials applications.
[32] Numan Hoda,et al. Determination of critical micelle concentration of polybutadiene-block-poly(ethyleneoxide) diblock copolymer by fluorescence spectroscopy and dynamic light scattering , 2013 .
[33] R. Savino,et al. Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non‐small lung cancer cells , 2012, Cell proliferation.
[34] J. Benoit,et al. Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride. , 2012, International journal of pharmaceutics.
[35] V. B. Konkimalla,et al. Polymeric modification and its implication in drug delivery: poly-ε-caprolactone (PCL) as a model polymer. , 2012, Molecular pharmaceutics.
[36] Caicun Zhou,et al. Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians , 2012, Therapeutic advances in medical oncology.
[37] J. Leroux,et al. Preparation of polyion complex micelles from poly(ethylene glycol)-block-polyions. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[38] V. Mourya,et al. Mixed micelle formation with hydrophobic and hydrophilic Pluronic block copolymers: implications for controlled and targeted drug delivery. , 2011, Colloids and surfaces. B, Biointerfaces.
[39] Afsaneh Lavasanifar,et al. Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[40] Ying-zheng Zhao,et al. Characterization of the Doxorubicin-Pluronic F68 Conjugate Micelles and Their Effect on Doxorubicin Resistant Human Erythroleukemic Cancer Cells , 2011 .
[41] B. Müller,et al. Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine. , 2010, International journal of pharmaceutics.
[42] Qiang Zhang,et al. Targeted Polymeric Micelle System for Delivery of Combretastatin A4 to Tumor Vasculature In Vitro , 2010, Pharmaceutical Research.
[43] M. Ranson,et al. A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva®, OSI-774) in patients with advanced solid tumors of epithelial origin , 2010, Cancer Chemotherapy and Pharmacology.
[44] L. Raez,et al. Erlotinib (tarceva) for the treatment of non-small-cell lung cancer and pancreatic cancer. , 2009, P & T : a peer-reviewed journal for formulary management.
[45] H. Aboul‐Enein,et al. FT-IR Spectrophotometric Analysis of Ascorbic Acid and Biotin and their Pharmaceutical Formulations , 2009 .
[46] N. Hynes,et al. ErbB receptors and signaling pathways in cancer. , 2009, Current opinion in cell biology.
[47] Jun Wang,et al. Self-assembled micelles of biodegradable triblock copolymers based on poly(ethyl ethylene phosphate) and poly(-caprolactone) as drug carriers. , 2008, Biomacromolecules.
[48] Y. Lee,et al. Biotin-conjugated block copolymeric nanoparticles as tumor-targeted drug delivery systems , 2007 .
[49] G. Kwon,et al. Polymeric micelles for drug delivery. , 2006, Current pharmaceutical design.
[50] Afsaneh Lavasanifar,et al. Polymeric micelles for drug delivery , 2006, Expert opinion on drug delivery.
[51] Marie-Hélène Dufresne,et al. Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[52] C. Müller-Goymann,et al. Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS). , 2005, International journal of pharmaceutics.
[53] R. Zhuo,et al. Methotrexate-loaded biodegradable polymeric micelles: preparation, physicochemical properties and in vitro drug release. , 2005, Colloids and surfaces. B, Biointerfaces.
[54] Lesley Seymour,et al. Erlotinib in lung cancer - molecular and clinical predictors of outcome. , 2005, The New England journal of medicine.
[55] S. Thibodeau,et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. , 2005, Chest.
[56] N. Normanno,et al. Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. , 2003, Endocrine-related cancer.
[57] Ping Qi-neng. Nanoparticulate systems for drug delivery , 2002 .
[58] K. Edwards,et al. Spherical Micelles and Other Self-Assembled Structures in Dilute Aqueous Mixtures of Poly(Ethylene Glycol) Lipids , 2001 .
[59] J. Kreuter,et al. Nanoparticulate systems for brain delivery of drugs. , 2001, Advanced drug delivery reviews.
[60] Leszek S. Zaremba,et al. Optimal portfolio choice under a liability constraint , 2000, Ann. Oper. Res..
[61] Christine Allen,et al. Nano-engineering block copolymer aggregates for drug delivery , 1999 .
[62] Y. Nagasaki,et al. Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L-lactide) block copolymers as potential drug carrier. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[63] R. Gref,et al. Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix. , 1999, Journal of controlled release : official journal of the Controlled Release Society.